1. Market Research
  2. > Healthcare Market Trends
  3. > CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Spain. It identifies the key trends in the country’s healthcare market, and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Spain has strong healthcare infrastructure and the Spanish National Health System provides free healthcare for all citizens. In 2013, Spain spent approximately $17.4 billion on R&D, and exported approximately $13 billion of pharmaceuticals.

The pharmaceutical market was worth approximately $29 billion in 2008, and is projected to decline to approximately $22.6 billion by 2020, at a negative Compound Annual Growth Rate (CAGR) of 2.1%. The primary reasons for this decline are the austerity measures implemented by the Spanish government. The factors influencing the pharmaceutical market are -
- The increasingly elderly population
- Promotion of low-priced medicines
- Promotion of generics
- The medical device market was valued at $7.1 billion in 2008, and is projected to grow at a CAGR of 4.5% to an estimated $12 billion in 2020.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Spain, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Roche, Novartis, Sanofi and GlaxoSmithKline, as well as profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, Roche, Medtronic, Abbott Laboratories and DePuy
- Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Spanish healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect the Spanish healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in the Spanish healthcare market

Table Of Contents

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain
1 Table of Contents
2 Introduction 19
2.1 GlobalData Report Guidance 19
3 Overview of the Pharmaceutical and Medical Device Markets 20
3.1 Pharmaceutical Market 20
3.1.1 Market Overview 20
3.1.2 Pharmaceutical Exports and Imports 23
3.1.3 Supply Channels 25
3.1.4 Market Segments 27
3.1.5 Overview of Top Five Disease Areas 33
3.1.6 Major Players 35
3.2 Medical Device Market 77
3.2.1 Market Overview 77
3.2.2 Overview of Top Five Segments 79
3.2.3 Diagnostic Market 93
3.2.4 Major Players 95
3.3 Market Drivers and Barriers 130
3.3.1 Drivers 130
3.3.2 Barriers 131
4 Market Access 133
4.1 Reimbursement and Payer Landscape 133
4.1.1 Overview of Healthcare System 133
4.1.2 Reimbursement Process 136
Overview of Insurance Providers 140
4.1.3 Patient Share in Healthcare Spending 142
4.1.4 Price Trend in Healthcare Services 143
4.1.5 Pricing Policies 144
4.2 Regulatory Landscape 147
4.2.1 Overview of Regulatory Agencies 147
4.2.2 Market Authorization Procedure for Pharmaceutical Products 149
4.2.3 Market Authorization Procedure for Medical Devices 165
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 170
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 173
4.2.6 Intellectual Property Rights 175
4.2.7 Clinical Trial Regulations 180
4.2.8 Pharmaceutical Advertising Regulations 182
4.2.9 Pharmacy Regulations 187
4.2.10 Labeling and Packaging Regulations 188
5 Country Analysis 191
5.1 Political Environment 191
5.1.1 Political Structure 191
5.1.2 Analysis of the Current Political Environment 192
5.1.3 Healthcare Policy Initiatives 194
5.2 Economic Landscape 196
5.3 Economic Indicators 200
5.3.1 Gross Domestic Product 200
5.3.2 Gross National Income 205
5.3.3 Inflation 206
5.3.4 Currency Exchange Rate 209
5.3.5 Foreign Direct Investment 210
5.3.6 Foreign Exchange Reserves 211
5.3.7 Trade Balance 212
5.3.8 General Government Structural Balance 214
5.3.9 General Government Net Debt 215
5.3.10 Major Industries 217
5.4 Demographics 218
5.4.1 Population 218
5.4.2 Education and Literacy 236
5.4.3 Employment 240
5.4.4 Disease Burden 241
5.5 Healthcare Infrastructure 244
5.5.1 Healthcare Facilities 244
5.5.2 Healthcare Parameters 249
5.5.3 Environmental Health 253
5.5.4 Healthcare Personnel 256
5.6 Healthcare Expenditure 259
5.6.1 Overview 259
5.6.2 Major Components of Healthcare Spending 260
5.6.3 Public and Private Sector Share 261
5.6.4 Spending in Healthcare, RandD 262
5.7 Trade Associations 263
5.7.1 Farmaindustria 263
5.7.2 The Spanish Society of Public Health and Health Services Administration 264
5.7.3 The Spanish Society of Health Informatics 265
5.7.4 Spanish Generic Medicines Association 265
5.8 Trade Fairs 266
6 Opportunities and Challenges 267
6.1 Opportunities 267
6.2 Challenges 268
7 Appendix 270
7.1 Abbreviations 270
7.2 Bibliography 275
7.3 Research Methodology 292
7.3.1 Coverage 292
7.3.2 Secondary Research 293
7.3.3 Forecasts 294
7.3.4 Expert Panel 294
7.4 Disclaimer 294

1.1 List of Tables
Table 1: Pharmaceutical Market, Spain, Revenue ($bn), 2008-2013 21
Table 2: Pharmaceutical Market, Spain, Revenue Forecast ($bn), 2014-2020 22
Table 3: Pharmaceutical Market, Spain, Pharmaceutical Exports and Imports ($bn), 2008-2013 24
Table 4: Pharmaceutical Market, Spain, Pharmaceutical Mark-Ups, 2014 26
Table 5: Pharmaceutical Market, Spain, Generics Market, Drug Consumption by Volume (%), 2008-2013 28
Table 6: Pharmaceutical Market, Spain, Red Biotechnology, Share of Diagnostics Pipeline by Disease Area (%), 2014 30
Table 7: Pharmaceutical Market, Spain, Red Biotechnology, Share of Therapeutics Pipeline by Disease Area (%), 2014 32
Table 8: Over the Counter Pharmaceutical Market, Spain, Share by Segment (%), 2011 33
Table 9: Pharmaceutical Market, Spain, Top Five Therapeutic Areas by Share of Drug Consumption (%), 2013 34
Table 10: Pharmaceutical Market, Pfizer, Major Products, Revenue ($bn) and Annual Growth (%), 2013 36
Table 11: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2014 37
Table 12: Pharmaceutical Market, Roche, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 44
Table 13: Pharmaceutical Market, Roche, Global, Late-stage Pipeline, 2014 46
Table 14: Pharmaceutical Market, Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 54
Table 15: Pharmaceutical Market, Novartis, Global, Planned Filings, 2014?2018 54
Table 16: Pharmaceutical Market, Sanofi, Global, Major Products, Revenue ($bn), 2013 64
able 17: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2014 64
able 18: Pharmaceutical Market, GlaxoSmithKline, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 69
Table 19: Pharmaceutical Market, GlaxoSmithKline, Global, Late-Stage Pipeline, 2014 69
Table 20: Medical Device Market, Spain, Revenue ($bn), 2008-2013 77
Table 21: Medical Device Market, Spain, Revenue Forecast ($bn), 2014-2020 78
Table 22: Medical Device Market, Spain, Top Five Segments, Revenue ($m) and Market Share (%), 2013 80
Table 23: Medical Device Market, Spain, In Vitro Diagnostics Revenue ($m), 2008-2013 81
Table 24: Medical Device Market, Spain, In Vitro Diagnostics, Sales Trend for Major Players, 2012 82
Table 25: Medical Device Market, Spain, Diabetes Care Devices Revenue ($m), 2008-2013 84
Table 26: Medical Device Market, Spain, Diabetes Care Devices, Sales Trend for Major Players, 2012 85
Table 27: Medical Device Market, Spain, Orthopedic Devices Revenue ($m), 2008-2013 86
Table 28: Medical Device Market, Spain, Orthopedic Devices, Sales Trend for Major Players, 2012 87
Table 29: Medical Device Market, Spain, Cardiovascular Devices Market ($m), 2008-2013 89
Table 30: Medical Device Market, Spain, Cardiovascular Devices Market, Sales Trend for Major Players, 2012 90
Table 31: Medical Device Market, Spain, Ophthalmic Devices Revenue ($m), 2008-2013 91
Table 32: Medical Device Market, Spain, Ophthalmic Devices, Sales Trend for Major Players, 2012 92
Table 33: Medical Device Market, Spain, Diagnostic Market, Revenue ($bn), 2008-2013 93
Table 34: Medical Device Market, Spain, Diagnostic Market, Revenue Forecast ($bn), 2014-2020 94
Table 35: Medical Device Market, Spain, Major Medical Device Companies Revenue, 2012 95
Table 36: Medical Device Market, Roche, Global, Major Products, 2014 102
Table 37: Medical Device Market, Medtronic, Global, Major Products, 2013 109
Table 38: Medical Device Market, Abbott, Global, Major Products, 2014 116
Table 39: Medical Device Market, Abbott, Global, Late-Stage Pipeline, 2014 117
Table 40: Healthcare System, Spain, Pharmaceutical Reimbursement Categories, 2014 137
Table 41: Healthcare Spending, Spain, Out-of-Pocket Expenditure (%), 2008-2013 142
Table 42: Market Access, Spain, Change in Average Price of Healthcare Services (%), 2008-2013 143
Table 43: Pricing Policies, Spain, Wholesaler and Pharmacist Margin on Drug Price, 2010 146
Table 44: Economic Indicators, Spain, Gross Domestic Product per Capita ($), 2008-2013 201
Table 45: Economic Indicators, Spain, Gross Domestic Product per Capita Forecast ($), 2014-2020 202
Table 46: Economic Indicators, Spain, Gross Domestic Product Annual Growth (%), 2008-2013 203
Table 47: Economic Indicators, Spain, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 204
Table 48: Economic Indicators, Spain, Gross National Income per Capita ($), 2008-2013 205
Table 49: Economic Indicators, Spain, Average Consumer Price Index, 2008-2013 207
Table 50: Economic Indicators, Spain, Average Consumer Price Index Forecast, 2014-2020 207
Table 51: Economic Indicators, Spain, Average Consumer Price Index Annual Change (%), 2008-2013 208
Table 52: Economic Indicators, Spain, Euro to Dollar Currency Exchange Rate, 2008-2013 209
Table 53: Economic Indicators, Spain, Foreign Direct Investment ($bn), 2008-2013 210
Table 54: Economic Indicators, Spain, Foreign Exchange Reserves ($bn), 2008-2013 211
Table 55: Economic Indicators, Spain, Imports of Goods and Services ($bn), 2008-2013 213
Table 56: Economic Indicators, Spain, Exports of Goods and Services ($bn), 2008-2013 213
Table 57: Economic Indicators, Spain, Government Structural Balance ($bn), 2008-2013 214
Table 58: Economic Indicators, Spain, General Government Net Debt (% of GDP), 2008-2013 215
Table 59: Economic Indicators, Spain, General Government Net Debt Forecast (% of GDP), 2014-2020 216
Table 60: Economic Indicators, Spain, Major Industries by Revenue ($bn) and Share (%), 2013 218
Table 61: Demographics, Spain, Population (million), 2008-2013 219
Table 62: Demographics, Spain, Population Forecast (million), 2014-2020 220
Table 63: Demographics, Spain, Population, Urban and Rural Population Share (%), 2008-2013 221
Table 64: Demographics, Spain, Population, Urban and Rural Population Share Forecast (%), 2014-2020 222
Table 65: Demographics, Spain, Population Distribution by Age Group (%), 2008-2013 224
Table 66: Demographics, Spain, Population Distribution by Age Group Forecast (%), 2014-2020 224
Table 67: Demographics, Spain, Births (per 1,000 Population), 2008-2013 225
Table 68: Demographics, Spain, Mortality (per 1,000 Population), 2008-2013 226
Table 69: Demographics, Spain, Major Causes of Mortality, 2012 228
Table 70: Demographics, Spain, Children Table 71: Demographics, Spain, Immunization Rate (%), 2008-2013 230
Table 72: Demographics, Spain, Major Causes of Male Mortality, 2012 232
Table 73: Demographics, Spain, Major Causes of Female Mortality, 2012 233
Table 74: Demographics, Spain, Gender Ratio (Male to Female), 2008-2013 234
Table 75: Demographics, Spain, Life Expectancy at Birth (Years), 2008-2013 235
Table 76: Demographics, Spain, Students Enrolled at Different Levels in Non-university Courses (%), 2012-2013 238
Table 77: Demographics, Spain, Students Enrolled at Different Levels in University Courses (%), 2012-2013 239
Table 78: Demographics, Spain, Unemployment Rate (%), 2008-2013 240
Table 79: Demographics, Spain, Distribution of Employment by Sectors (%), 2013 241
Table 80: Demographics, Spain, Number of Hospital Admissions and Diseases Diagnosed, 2012 242
Table 81: Demographics, Spain, Major Diseases, Disability-Adjusted Life Years (per 100,000 Population), 2004 244
Table 82: Healthcare Infrastructure, Spain, Number of Hospitals, 2008-2013 245
Table 83: Healthcare Infrastructure, Spain, Number of Hospitals by Type of Treatment, 2008-2013 246
Table 84: Healthcare Infrastructure, Spain, Number of Hospitals by Sector, 2008-2013 247
Table 85: Healthcare Infrastructure, Spain, Diagnostic Units (per 1,000,000 Population), 2008-2013 248
Table 86: Healthcare Infrastructure, Spain, Hospital Beds (per 1,000 Population), 2008-2013 249
Table 87: Healthcare Infrastructure, Spain, Number of Hospital Beds by Sector, 2008-2013 250
Table 88: Healthcare Infrastructure, Spain, Hospital Beds by type of treatment, 2008-2013 251
Table 89: Healthcare Infrastructure, Spain, Doctors (per 100,000 Population), 2008-2013 252
Table 90: Healthcare Infrastructure, Spain, PM10 (µg/m3), 2008-2013 254
Table 91: Healthcare Infrastructure, Spain, CO2 Emissions (Million Metric Tons), 2008-2013 256
Table 92: Healthcare Infrastructure, Spain, Nurses (per 1,000 Population), 2008-2013 257
Table 93: Healthcare Infrastructure, Spain, Pharmacists (per 1,000 Population), 2008-2013 258
Table 94: Healthcare Infrastructure, Spain, Dentists (per 1,000 Population), 2008-2013 259
Table 95: Healthcare Expenditure, Spain, Healthcare Expenditure (% of GDP), 2008-2013 260
Table 96: Healthcare Expenditure, Spain, Major Components of Healthcare Expenditure (%), 2008-2013 261
Table 97: Healthcare Expenditure, Spain, Healthcare Expenditure, Public-Private Share (%), 2008-2013 262
Table 98: Healthcare Expenditure, Spain, Research and Development Expenditure by Field (%), 2012 263
Table 99: Trade Fairs, Spain, Major Healthcare Trade Fairs, 2015 266

1.2 List of Figures
Figure 1: Pharmaceutical Market, Spain, Revenue ($bn), 2008-2013 21
Figure 2: Pharmaceutical Market, Spain, Revenue Forecast ($bn), 2014-2020 22
Figure 3: Pharmaceutical Market, Spain, Pharmaceutical Exports and Imports ($bn), 2008-2013 23
Figure 4: Pharmaceutical Market, Spain, Supply Channel, 2010 26
Figure 5: Pharmaceutical Market, Spain, Generics Market, Drug Consumption by Volume (%), 2008-2013 28
Figure 6: Pharmaceutical Market, Spain, Red Biotechnology, Share of Diagnostics Pipeline by Disease Area (%), 2014 30
Figure 7: Pharmaceutical Market, Spain, Red Biotechnology, Share of Therapeutics Pipeline by Disease Area, 2014 31
Figure 8: OTC Pharmaceutical Market, Spain, Segment Share (%), 2011 33
Figure 9: Medical Device Market, Spain, Revenue ($bn), 2008-2013 77
Figure 10: Medical Device Market, Spain, Revenue Forecast ($bn), 2014-2020 78
Figure 11: Medical Device Market, Spain, Top Five Segments, Revenue ($m), 2013 79
Figure 12: Medical Device Market, Spain, In Vitro Diagnostics Revenue ($m), 2008-2013 81
Figure 13: Medical Device Market, Spain, In Vitro Diagnostics, Sales Trend for Major Players, Revenue ($m), 2008-2012 82
Figure 14: Medical Device Market, Spain, Diabetes Care Devices Revenue ($m), 2008-2013 83
Figure 15: Medical Device Market, Spain, Diabetes Care Devices, Sales Trend for Major Players, Revenue ($m), 2008-2012 84
Figure 16: Medical Device Market, Spain, Orthopedic Devices Revenue ($m), 2008-2013 86
Figure 17: Medical Device Market, Spain, Orthopedic Devices, Sales Trend for Major Players, Revenue ($m), 2008-2012 87
Figure 18: Medical Device Market, Spain, Cardiovascular Devices Market ($m), 2008-2013 88
Figure 19: Medical Device Market, Spain, Cardiovascular Devices Market, Sales Trend for Major Players, Revenue ($m), 2008-2012 89
Figure 20: Medical Device Market, Spain, Ophthalmic Devices Revenue ($m), 2008-2013 91
Figure 21: Medical Device Market, Spain, Ophthalmic Devices, Sales Trend for Major Players, Revenue ($m), 2008-2012 92
Figure 22: Medical Device Market, Spain, Diagnostic Market, Revenue ($bn), 2008-2013 93
Figure 23: Medical Device Market, Spain, Diagnostic Market, Revenue Forecast ($bn), 2014-2020 94
Figure 24: Medical Device Market, Spain, Major Medical Device Companies, Revenue ($m), 2012 95
Figure 25: Healthcare Market, Spain, Drivers and Barriers, 2014 132
Figure 26: Healthcare System, Spain, Organization of the Spanish National Health System, 2014 133
Figure 27: Healthcare System, Spain, Health Technology Assessment Process, 2014 139
Figure 28: Healthcare Spending, Spain, Out-of-Pocket Expenditure (%), 2008-2013 142
Figure 29: Market Access, Spain, Change in Average Price of Healthcare Services (%), 2008-2013 143
Figure 30: Regulatory Landscape, Spain, AEMPS Organization, 2014 149
Figure 31: Market Authorization, Spain, National Procedure, 2014 153
Figure 32: Market Authorization, Spain, Centralized Procedure, Pre-Submission, 2014 156
Figure 33: Market Authorization, Spain, Centralized Procedure, Pre-Opinion Phase, 2014 158
Figure 34: Market Authorization, Spain, Centralized Procedure, Post-Opinion Phase, 2014 160
Figure 35: Market Authorization, Spain, Decentralized Procedure, 2014 162
igure 36: Market Authorization, Spain, Mutual Recognition Procedure, 2014 164
Figure 37: Market Authorization, Spain, Conformity Assessment of Class I Medical Devices, 2014 166
Figure 38: Market Authorization, Spain, Conformity Assessment of Class IIa Medical Devices, 2014 167
Figure 39: Market Authorization, Spain, Conformity Assessment of Class IIb Medical Devices, 2014 168
Figure 40: Market Authorization, Spain, Conformity Assessment of Class III Medical Devices, 2014 169
Figure 41: Economic Indicators, Spain, Gross Domestic Product per Capita ($), 2008-2013 201
Figure 42: Economic Indicators, Spain, Gross Domestic Product per Capita Forecast ($), 2014-2020 202
Figure 43: Economic Indicators, Spain, Gross Domestic Product Annual Growth (%), 2008-2013 203
Figure 44: Economic Indicators, Spain, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 204
Figure 45: Economic Indicators, Spain, Gross National Income per Capita ($), 2008-2013 205
Figure 46: Economic Indicators, Spain, Average Consumer Price Index, 2008-2013 206
Figure 47: Economic Indicators, Spain, Average Consumer Price Index Forecast, 2014-2020 207
Figure 48: Economic Indicators, Spain, Average Consumer Price Index Annual Change (%), 2008-2013 208
Figure 49: Economic Indicators, Spain, Euro to Dollar Currency Exchange Rate, 2008-2013 209
Figure 50: Economic Indicators, Spain, Foreign Direct Investment ($bn), 2008-2013 210
Figure 51: Economic Indicators, Spain, Foreign Exchange Reserves ($bn), 2008-2013 211
Figure 52: Economic Indicators, Spain, Imports of Goods and Services ($bn), 2008-2013 212
Figure 53: Economic Indicators, Spain, Exports of Goods and Services ($bn), 2008-2013 213
Figure 54: Economic Indicators, Spain, Government Structural Balance ($bn), 2008-2013 214
Figure 55: Economic Indicators, Spain, General Government Net Debt (% of GDP), 2008-2013 215
Figure 56: Economic Indicators, Spain, General Government Net Debt Forecast (% of GDP), 2014-2020 216
Figure 57: Economic Indicators, Spain, Major Industries by Revenue ($bn), 2013 217
Figure 58: Demographics, Spain, Population (million), 2008-2013 219
Figure 59: Demographics, Spain, Population Forecast (million), 2014-2020 220
Figure 60: Demographics, Spain, Population, Urban and Rural Population Share (%), 2008-2013 221
Figure 61: Demographics, Spain, Population, Urban and Rural Population Share Forecast (%), 2014-2020 222
Figure 62: Demographics, Spain, Population Distribution by Age Group (%), 2008-2013 223
Figure 63: Demographics, Spain, Population Distribution by Age Group Forecast (%), 2014-2020 224
Figure 64: Demographics, Spain, Births (per 1,000 Population), 2008-2013 225
Figure 65: Demographics, Spain, Mortality (per 1,000 Population), 2008-2013 226
Figure 66: Demographics, Spain, Major Causes of Mortality, 2012 227
Figure 67: Demographics, Spain, Children Figure 68: Demographics, Spain, Immunization Rate (%), 2008-2013 230
Figure 69: Demographics, Spain, Major Causes of Male Mortality, 2012 231
Figure 70: Demographics, Spain, Major Causes of Female Mortality, 2012 232
Figure 71: Demographics, Spain, Gender Ratio (Male to Female), 2008-2013 234
Figure 72: Demographics, Spain, Life Expectancy at Birth (Years), 2008-2013 235
Figure 73: Demographics, Spain, Students Enrolled at Different Levels in Non-university Courses (%), 2012-2013 237
Figure 74: Demographics, Spain, Students Enrolled at Different Levels in University Courses (%), 2012-2013 239
Figure 75: Demographics, Spain, Unemployment Rate (%), 2008-2013 240
Figure 76: Demographics, Spain, Distribution of Employment by Sector (%), 2013 241
Figure 77: Demographics, Spain, Number of Hospital Admissions and Diseases Diagnosed, 2012 242
Figure 78: Demographics, Spain, Major Diseases, Disability-Adjusted Life Years (per 100,000 Population), 2004 243
Figure 79: Healthcare Infrastructure, Spain, Number of Hospitals, 2008-2013 245
Figure 80: Healthcare Infrastructure, Spain, Number of Hospitals by Type of Treatment, 2008-2013 246
Figure 81: Healthcare Infrastructure, Spain, Number of Hospitals by Sector, 2008-2013 247
Figure 82: Healthcare Infrastructure, Spain, Diagnostic Units (per 1,000,000 Population), 2008-2013 248
Figure 83: Healthcare Infrastructure, Spain, Hospital Beds (per 1,000 Population), 2008-2013 249
Figure 84: Healthcare Infrastructure, Spain, Number of Hospital Beds by Sector, 2008-2013 250
Figure 85: Healthcare Infrastructure, Spain, Hospital Beds by Type of Treatment Provided, 2008-2013 251
Figure 86: Healthcare Infrastructure, Spain, Doctors (per 100,000 Population), 2008-2013 252
Figure 87: Healthcare Infrastructure, Spain, PM10 (µg/m3), 2008-2013 254
Figure 88: Healthcare Infrastructure, Spain, CO2 Emissions (Million Metric Tons), 2008-2013 255
Figure 89: Healthcare Infrastructure, Spain, Nurses (per 1,000 Population), 2008-2013 256
Figure 90: Healthcare Infrastructure, Spain, Pharmacists (per 1,000 Population), 2008-2013 257
Figure 91: Healthcare Infrastructure, Spain, Dentists (per 1,000 Population), 2008-2013 258
Figure 92: Healthcare Expenditure, Spain, Healthcare Expenditure (% of GDP), 2008-2013 259
Figure 93: Healthcare Expenditure, Spain, Major Components of Healthcare Expenditure (%), 2008-2013 260
Figure 94: Healthcare Expenditure, Spain, Healthcare Expenditure, Public-Private Share (%), 2008-2013 262
Figure 95: Healthcare Expenditure, Spain, Research and Development Expenditure by Field (%), 2012 263
Figure 96: Healthcare Market, Spain, Opportunities and Challenges, 2014 269

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Healthcare IT Market by Product End User - Global Forecast to 2021

Healthcare IT Market by Product End User - Global Forecast to 2021

  • $ 8150
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global healthcare IT market is expected to grow at a CAGR of 15.9% from 2016 to 2021 and reach USD 280.25 billion. Growing need to manage regulatory compliance through healthcare IT solutions, government ...

Ultrasound Market by Technology, Display, Portability, Application, End User - Forecast to 2021

Ultrasound Market by Technology, Display, Portability, Application, End User - Forecast to 2021

  • $ 7150
  • Industry report
  • March 2017
  • by MarketsandMarkets

The ultrasound market is expected to reach USD 6.86 billion by 2021 at a CAGR of 5.2% during 2016-2021. North America and Europe held the largest share of the market in 2016; however, the Asia-Pacific ...

EU5 Computed Tomography (CT) Systems Market Outlook to 2022

EU5 Computed Tomography (CT) Systems Market Outlook to 2022

  • $ 5995
  • Industry report
  • February 2017
  • by GlobalData

EU5 Computed Tomography (CT) Systems Market Outlook to 2022 Summary GlobalData’s new report, "EU5 Computed Tomography (CT) Systems Market Outlook to 2022", provides key market data on the EU5 Computed ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.